Results 311 to 320 of about 356,203 (328)

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023

exaly  

Hypochondroplasia: Molecular Analysis of the Fibroblast Growth Factor Receptor 3 Gene

Annals of the New York Academy of Sciences, 1996
G A, Bellus, I, McIntosh, J, Szabo, A, Aylsworth, I, Kaitila, C A, Francomano   +5 more
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

Fibroblast Growth Factor Receptor 3 and Multiple Myeloma

2008
Victor Hugo Jiménez-Zepeda, A. Keith Stewart   +1 more
openaire   +1 more source

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Global cancer statistics, 2012

Ca-A Cancer Journal for Clinicians, 2015
Frank Bray, Rebecca L Siegel, Joannie Lortet-Tieulent   +2 more
exaly  

Global cancer statistics

Ca-A Cancer Journal for Clinicians, 2011
Frank Bray
exaly  

Cancer treatment and survivorship statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Kimberly D Miller, Leticia Nogueira, Angela B Mariotto   +2 more
exaly  

Cancer treatment and survivorship statistics, 2016

Ca-A Cancer Journal for Clinicians, 2016
Kimberly D Miller, Angela B Mariotto
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly